Autoimmune haemolytic anaemia and antiphospholipid antibodies in paediatrics: a systematic review and meta-analysis

Clin Rheumatol. 2021 May;40(5):1967-1973. doi: 10.1007/s10067-020-05436-2. Epub 2020 Oct 2.

Abstract

Introduction/objective: The relationship between autoimmune haemolytic anaemia (AIHA) and antiphospholipid antibodies (aPL) has never been addressed via a meta-analysis in the paediatric age group. We evaluated the link between AIHA and aPL in childhood systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS).

Methods: EMBASE and PubMed were screened from inception to May 2020 and Peto's odds ratio for rare events was employed for the between group comparisons.

Results: The meta-analysis included 11 articles for a total of 575 children: the pooled prevalence of AIHA was greater in (1) IgG aCL-positive than IgG aCL-negative children (39.7% vs 20.9%, p = 0.005); (2) in APS-positive than APS-negative SLE children (36.8% vs 13.2%, p = 0.01); and (3) in SLE-related APS than in primary APS children (53% vs 16.2%, p = 0.008).

Conclusions: The pooled prevalence of AIHA is greatest in SLE with aPL/APS, low-moderate in SLE without aPL/APS, and lowest in primary APS. Key Points • Antiphospholipid antibodies strongly relate to autoimmune haemolytic anaemia. • Autoimmune haemolytic anaemia is more common in systemic lupus erythematosus with antiphospholipid antibodies.

Keywords: Antiphospholipid syndrome; Autoimmune haemolytic anaemia; Lupus.

Publication types

  • Meta-Analysis
  • Systematic Review

MeSH terms

  • Anemia, Hemolytic, Autoimmune* / complications
  • Antibodies, Antiphospholipid
  • Antiphospholipid Syndrome* / complications
  • Child
  • Humans
  • Lupus Erythematosus, Systemic* / complications
  • Pediatrics*

Substances

  • Antibodies, Antiphospholipid